Codex Biosciences International Private Limited, a active private limited company, was established on 09 February 2000 in Visakhapatnam, Andhra Pradesh, India. Engaging in fisheries & aquaculture within the manufacturing sector, it holds CIN: U51397AP2000PTC033511. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.61 M.
Formerly known as Coion Technologies Private Limited. It upholds a compliant status. Employing 20 professional, Its leadership includes Rajakumari Challagulla (Director), Vidya Sagar Challagulla (Managing Director). Past directors included Vidya Sagar Challagulla. It holds ₹3.70 Cr open charges and ₹3.02 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No. 49-38-14/7, Beside Icwai Building, Nggo'S Colony, Akkayapalem,, Visakhapatnam, Andhra Pradesh, 530016.
U51397AP2000PTC033511
033511
09 February 2000
₹5.00 M
₹2.61 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Codex Biosciences International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajakumari Challagulla | Director | 30 Nov 2001 | Current |
| Vidya Sagar Challagulla | Managing Director | 09 Feb 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Nov 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Codex Biosciences International Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.99% increase. The company also saw a substantial improvement in profitability, with a 18.46% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Codex Biosciences International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹37,000,000.00
₹30,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2023 | Others | ₹4.50 M | Open |
| 08 Apr 2022 | Others | ₹2.90 M | Open |
| 16 Sep 2020 | Others | ₹3.30 M | Open |
| 08 Mar 2019 | Others | ₹2.63 Cr | Open |
| 22 Nov 2011 | Others | ₹2.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Codex Biosciences International has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Codex Biosciences International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Codex Biosciences International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Codex Biosciences International Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Codex Biosciences International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
A charge with Others amounted to Rs. 4.50 M with Charge ID 100665861 was registered on 11 Jan 2023. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 2.90 M with Charge ID 100556284 was registered on 08 Apr 2022. was completed.
Progress on A charge with Others amounted to Rs. 3.30 M with Charge ID 100368823 was registered on 16 Sep 2020. was documented.
The activity A charge registered on 22 Nov 2011 via Charge ID 10320669 with Others was fully satisfied on 15 Mar 2019. was completed.
The CIN of Codex Biosciences International Private Limited is U51397AP2000PTC033511.
Codex Biosciences International Private Limited is headquartered at D.No. 49-38-14/7, Beside Icwai Building, Nggo'S Colony, Akkayapalem,, Visakhapatnam, Andhra Pradesh, 530016.
Codex Biosciences International Private Limited was incorporated on 09 February 2000.
The current directors of Codex Biosciences International Private Limited are
The primary industry of Codex Biosciences International Private Limited is Manufacturing.
Codex Biosciences International Private Limited is unlisted.
The authorized capital of Codex Biosciences International Private Limited is ₹5.00 M, and the paid-up capital is ₹2.61 M.
The compliance status of Codex Biosciences International Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX